Eurofins competence center in DMPK.

Growing complexity, longer timelines, quality and confidentiality issues, high personnel turnover, prolonged searches for expertise along with unexpected costs: these are some of the most daunting challenges you face today when outsourcing priority preclinical and clinical research studies.

Eurofins ADME BIOANALYSES is a GLP compliant CRO founded in 1987. In recognition of the challenges you face, we offer our expertise in the fields of pharmacokinetics, metabolism and bioanalysis.

A proven high quality of services

Since the establishment of Eurofins ADME BIOANALYSES, we have been successfully inspected by ANSM every 2 years.[1].

With our expertise and comprehensive range of EMA and FDA compliant services[2], we are well positioned to be your professional and valued partner.

The quality and reliability of our performance is best reflected by the longevity of the numerous collaborations we maintain with leading international companies.

[1] ANSM : Agence Nationale de Sécurité des Médicaments

[2] Successful FDA General Facility inspection July 2009



  • We are increasing our capacities by building a new 1800sqm facilities next to our existing lab.
  • Eurofins ADME BIOANALYSES expands its bioanalysis expertise for small molecule, protein and antibody PK and immunogenicity. Our experts can advise you and optimize your development program according to current regulations.